This inventor holds 1 USPTO granted patent, plus 3 CIPO patents and 1 EPO patent. Top assignee: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Aifeng Lu: Innovator in Pharmaceutical Development
Introduction
Aifeng Lu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug formulations. His work focuses on enhancing the bioavailability and efficacy of pharmaceutical compounds.
Latest Patents
Aifeng Lu holds a patent for a crystal form of tenofovir prodrug, which includes a preparation method and a method of use. The patent describes a crystal form of 9-[(R)-2-[[(S)-[[[1-(isopropoxycarbonyl)-1-methyl]ethyl]amino]phenoxyphosphinyl]methoxyl]propyl]adenine fumarate. This crystal form is characterized by an X-ray powder diffraction (XRPD) spectrum with specific diffraction peaks, indicating its unique properties. The crystal form boasts high bioavailability, significant efficacy, good stability, high yield, and high purity. These attributes contribute to improved drug production quality and assist in the selection and design of drug administration routes.
Career Highlights
Aifeng Lu is associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where he continues to innovate in pharmaceutical research and development. His work has been instrumental in advancing drug formulations that enhance therapeutic outcomes.
Collaborations
Aifeng Lu collaborates with talented professionals in his field, including Ming Chen and Chengyao Tian. Their combined expertise fosters a productive environment for innovation and development in pharmaceuticals.
Conclusion
Aifeng Lu's contributions to pharmaceutical innovation, particularly through his patented work, highlight his role as a key figure in enhancing drug formulations. His efforts continue to impact the pharmaceutical industry positively.